Digital Pathology Systems: A Global Strategic Business Report
San Jose, California (PRWEB) January 12, 2015
Follow us on LinkedIn – Digital pathology broadly refers to application of digital information technologies to support pathology research and practice. A dynamic, image-driven model, digital pathology helps pathologists, histology personnel and laboratory managers to acquire, manage and interpret pathology-related information derived from digitized glass slides of specimens or tissue samples. Digital pathology systems are witnessing growth in adoption in various end-use applications such as diagnostic tests, drug discovery & development, education & training, and academic research in human pathology, veterinary pathology, oral pathology and forensic pathology. Major factors driving growth in demand include inherent benefits offered such as enhanced workflow efficiency, reduced costs of operating pathological processes, quicker acquisition of high resolution images, and faster and accurate diagnosis.
In addition, the need for compliance with regulatory standards related to information management, improving efficiency in drug development, emergence of companion diagnostics and benefits offered in the field of cancer diagnosis are also driving growth. Benefits such as the ability to share pathology cases among colleagues with ease, enable quick consultation with specialists, and allow quick access to archived digital pathology information are driving interest and adoption of digital pathology across clinical labs worldwide. Demand is also being driven by scarcity of skilled pathologists and excess workloads on pathology teams in research labs and hospitals.
Technological advances are playing a pivotal role in encouraging adoption of digital pathology systems. Development in digital imaging techniques and improvements in system processing speeds, are driving demand. Significant advances have been achieved in the area of slide scanners, including improvement in scanner throughput. Developments are also afoot in the area of software, which is becoming progressively less complex.
As stated by the new market research report on Digital Pathology Systems, the United States represents the single largest market worldwide. Asia-Pacific is forecast to emerge as the fastest growing market with a CAGR of 15.2% over the analysis period. Increasing awareness over the benefits of digital pathology, establishment of dedicated pathology labs to meet growing healthcare needs, increasing workload of pathologists and growing use in cancer diagnosis, represent factors driving growth in the region.
Major players in the market include 3DHISTECH Ltd., AccelPath Inc., Apollo PACS Inc., Corista LLC, Leica Microsystems GmbH, MikroScan Technologies Inc., Olympus America Inc., Omnyx LLC, and Ventana Medical Systems Inc., among others.
The research report titled "Digital Pathology Systems: A Global Strategic Business Report" announced by Global Industry Analysts, Inc., provides a comprehensive review of trends, issues, strategic industry activities, and profiles of major companies worldwide. The report provides market estimates and projections in US$ for all major geographic markets including the US, Canada, Japan, Europe (France, Germany, Italy, UK, Spain and Rest of Europe), Asia Pacific, Latin America and Rest of World.
For more details about this comprehensive market research report, please click here
About Global Industry Analysts, Inc.
Global Industry Analysts, Inc., (GIA) is a leading publisher of off-the-shelf market research. Founded in 1987, the company currently employs over 800 people worldwide. Annually, GIA publishes 1500+ full-scale research reports and analyzes 40,000+ market and technology trends while monitoring more than 126,000 Companies worldwide. Serving over 9500 clients in 27 countries, GIA is recognized today, as one of the world's largest and reputed market research firms.
Global Industry Analysts, Inc.
Web Site: http://www.StrategyR.com/
Global Industry Analysts, Inc. 6150 Hellyer Ave., San Jose CA 95138, USA, All Rights Reserved.